David Gómez-Almaguer
Universidad Autónoma de Nuevo León
401 Papers
1.3K Citations
David Gómez-Almaguer is an academic researcher from Universidad Autónoma de Nuevo León. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 30, co-authored 309 publications.
Chat about Author
Papers
Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor.
José Carlos Jaime-Pérez,Mónica Andrea Pinzón-Uresti,Raúl Alberto Jiménez-Castillo,Julia E. Colunga-Pedraza,Oscar González-Llano,David Gómez-Almaguer +5 more
TL;DR: A high rate of very early, CNS, and BM relapse with a considerably low 5-year OS requiring reassessment of therapy was documented, and organomegaly at diagnosis was a highly significant clinical predictor for relapse.
Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible.
Olga G. Cantú-Rodríguez,Alberto Vazquez-Mellado,Juan Luis Gonzalez-Treviño,David Mauricio Martínez-Garza,Andrés Gómez-De León,Jose Angel Hawing-Zarate,José Carlos Jaime-Pérez,César Homero Gutiérrez-Aguirre,Andrea Cecilia Garza-Acosta,Consuelo Mancías-Guerra,Oscar González-Llano,Graciela Alejandra González-Cantú,Miguel Angel Herrera-Rojas,Isabel Sada-Ovalle,David Gómez-Almaguer +14 more
TL;DR: Topical CsA as a prophylactic measure for oGVHD, administered over a period of 1 year after grafting, is safe and feasible and may decrease the incidence of ophthalmic manifestations of GVHD.
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL).
Brady E Beltran,Luis Villela,María Alejandra Torres,Victoria Otero,Lorena Fiad,Camila Peña,Maria Elena Cabrera,Pilar León,Henry Idrobo,Denisse Castro,Sally Rose Paredes,Ivan Perdomo,Virginia Abello,Christine Rojas,Ana Florencia Ramirez-Ibarguen,Myrna Candelaria,Fernando Pérez-Jacobo,Efren Montaño-Figueroa,Carlos Best,Andrés Gómez-De León,David Gómez-Almaguer,Guillermo J. Ruiz-Argüelles,José Ascención Hernández-Hernández,Luis Malpica,Eduardo M. Sotomayor,Jorge J. Castillo +25 more
TL;DR: Based on the results of this multi-institutional study, NLR ≥ 4 emerges as an adverse prognostic factor in Latin American patients with DLBCL treated with chemoimmunotherapy.
Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients
José Gerardo González-González,Leonor Guadalupe Mireles-Zavala,Rene Rodriguez-Gutierrez,David Gómez-Almaguer,Fernando J. Lavalle-González,Héctor Eloy Tamez-Pérez,Gerardo González-Saldivar,Jesús Zacarías Villarreal-Pérez +7 more
TL;DR: High-dose prednisone for 2 to 3 months produced an elevated incidence of diabetes, usually with mild hyperglycemia occurring between the second and fourth week, normalizing spontaneously in all cases.
Point of care thoracic ultrasound versus chest computed tomography in the approach of febrile neutropenia patients: A diagnostic accuracy cohort study
Erick Joel Rendón-Ramírez,Karla Belén Treviño-García,Samantha P. Peña-Lozano,Mario Alonso Treviño,Roberto Mercado-Longoria,Homero Náñez-Terreros,Matías Salinas-Chapa,David Gómez-Almaguer,Olga G. Cantú-Rodríguez,Héctor Enrique Cedillo-Huerta,H. A. Vaquera-Alfaro,Perla R Colunga-Pedraza +11 more
TL;DR: It is concluded that TUS is a promising screening test for immunocompromised individuals and good diagnostic performance of TUS compared to CT for the detection of pulmonary findings highly suggestive of pathology with high accuracy and reproducibility.